Skip to main content
Screener/Healthcare/Biotechnology

EYPT — EyePoint Pharmaceuticals, Inc.

NASDAQ
$14.45+0.07 (+0.45%)
Small CapUnder $20HealthcareHigh Beta
$7.94
$19.11
$14.38
$14.85
EPS (TTM)$-3.50
P/E Ratio-4.82
Dividend Yield—
Market Cap$1.14B
Volume493K
Prev Close$14.38
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$696K-$84.8M$-0.9924.1%-12188.5%
Q4 '25$620K-$67.6M$-0.8139.5%-10904.7%
Q3 '25$966K-$59.7M$-0.8525.4%-6183.4%
Q2 '25$5.3M-$59.4M$-0.8596.9%-1114.3%
Q1 '25$24.5M-$45.2M$-0.6596.7%-184.8%
Q4 '24$11.6M-$41.4M$-0.6493.0%-357.3%
Q3 '24$10.5M-$29.4M$-0.5493.0%-279.0%
Q2 '24$9.5M-$30.8M$-0.5885.2%-325.3%
Get Your Daily Market Recap